Dr. Steven M. Albert, sma10@Columbia.edu
Epidemiologic studies investigating the cognitive basis of functional competency of patients with HIV, Alzheimer disease and ALS. Ongoing studies of disease-related changes contributing to patient quality of life, nursing home placement, hospitalization and home care costs.
Dr. Jennie Kline, jkk3@columbia.edu
Epidemiology of spontaneous abortion; chromosomal disorders including trisomy; autism and other selected developmental disorders.
Dr. Ruth Ottman, ro6@columbia.edu
Neuroepidemiology and genetic studies of epilepsy, Parkinson disease and ALS.
Dr. Nicole Schupf, ns24@columbia.edu
Genetic epidemiology of Down syndrome and Alzheimer disease.
Dr. Zena Stein, zas2@columbia.edu
Epidemiology of mental retardation and developmental brain diseases.
Dr. W. Allen Hauser, wah1@columbia.edu
Associate Director (see Neuroepidemiology under the Comprehensive Epilepsy Center).
Dr. Karen S. Marder, ksm1@columbia.edu
(see Aging and Dementia)
Dr. Karen L. Bell, klb1@columbia.edu
(see Aging and Dementia)
Dr. Laurence C. Honig, lh456@columbia.edu
Dr. Elan D. Louis, edl2@columbia.edu
(see Movement Disorders)
Dr. Scott Small, sas68@columbia.edu
(see Aging and Dementia)
Dr. Yaakov Stern, Head, Cognitive Neuroscience, ys11@columbia.edu
Experimental and neuroimaging approaches to cognitive issues in normal aging and diseases of the aging brain (including Alzheimer, Parkinson and Huntington diseases). Current experimental cognitive studies include: source memory, working memory, priming, and the interplay between explicit recollection and familiarity in normal aging; basic timing mechanisms in normal aging and Parkinson disease; language and working memory in Alzheimer disease; and effects of literacy, education, ethnicity and acculturation on neuropsychological task performance in cognitive neuroimaging. Cognitive neuroimaging studies include: network changes in mediating recognition and working memory and cognitive reserve in normal aging and Alzheimer disease (H2 15O PET and fMRI); age priming in young adults and normal aging (ER-fMRI) executive function in normal aging and Huntington disease (fMRI), and effects of estrogen on recognition and source memory in elderly women (ERP).